Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine

Nuclear Medicine and Biology

Volumn 30, Issue 6, 2003, Pages 669-679

  Orlefors H ^a   Sundin, A ^a,b   Fasth, K J ^b   Oberg K ^a   Langstrom B ^b   Eriksson, B ^a   Bergstrom M ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA INTERFERON; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANGIOPEPTIN; CISPLATIN; DOPAMINE 1 RECEPTOR; ETOPOSIDE; FLUOROURACIL; HARMINE; HARMINE C 11; MUSCARINIC RECEPTOR; OCTREOTIDE; SEROTONIN 2A RECEPTOR; STREPTOZOCIN; TRACER; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CANCER SURGERY; CARCINOID; CARCINOID SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCAGONOMA; HUMAN; HUMAN TISSUE; INSULINOMA; INTESTINE; LIVER; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MIDGUT; MONOAMINERGIC SYSTEM; NEUROENDOCRINE TUMOR; NONHUMAN; PANCREAS ISLET CELL TUMOR; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RAT; TUMOR SCINTISCANNING;

EID: 0142011521     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00034-9     Document Type: Article

References (38)

1. Ahlström H., Eriksson B., Bergström M., Bjurling P., Langstrom B., Oberg K. Pancreatic neuroendocrine tumors diagnosis with PET . Radiol. 1995:1995;333-337.
2. Ammon H.P., Grimm A., Lutz S., Wagner-Teschner D., Handel M., Hagenloh I. Islet glutathione, and insulin release. Diabetes. 1980:1980;830-834.
3. Barasch J.M., Mackey H., Tamir H., Nunez E.A., Gershon M.D., et al. Induction of a neural phenotype in a serotonergic endocrine cell derived from the neural crest. J. Neurosci. 1987:1987;2874-2883.
4. Bergstrom K.A., Halldin C., Hall H., Lundkvist C., Ginovart N., Swahn C.G., Farde L. In vitro and in vivo characterisation of nor-beta-CIT a potential radioligand for visualisation of the serotonin transporter in the brain . Eur. J. Nucl. Med. 1997:1997;596-601.
5. Bergström M. Positron emission tomography in tumor diagnosis and treatment follow up. Acta Oncol. 1993:1993;183-188.
6. 11C-harmine as a tracer for monoamine oxidase A (MAO-A) in vitro, and in vivo studies . Nucl. Med. Biol. 1997:1997;287-293.
7. 11C-labelled MAO-inhibitors, and their in vivo uptake kinetics in rhesus monkey brain. Nucl. Med. Biol. 1997:1997;381-388.
8. Bergstrom M., Westerberg G., Németh G., Traut M., Gross M., Greger G., Muller-Peltzer H., Safer A., Eckernas S.A., Grahnér A., Langstrom B. MAO-A inhibition in brain after dosing of Esuprone, Moclobemide and placebo in healthy volunteers-in vivo studies with positron emission tomography. Eur. J. Clin. Pharmacol. 1997:1997;121-128.
9. Berrey M.D., Juorio A.V., Paterson I.A. The functional role of monoaminoxidasis A and B in mamalian central nervous system. Prog. Neurobiol. 1994:1994;375-391.
10. Dostert P.L., Strolin-Benedetti M., Tipton K.F. Interactions of monoamine oxidase with substrates, and inhibitors. Med. Res. Rev. 1989:1989;45-89.
11. Eriksson B., Arnberg H., Lindgren P.G., Lorelius L.E., Magnusson A., Lundqvist G., Skogseid B., Wide L., Wilander E., Oberg K. Neuroendocrine pancreatic tumors clinical presentation, biochemical, and histopathological findings in 84 patients . J. Intern. Med. 1990:1990;103-113.
12. Eriksson B., Öberg K. Summing up 15 years of somatostatin alalog therapy in neuroendocrine tumors future outlook . Ann. Oncol. 10:(suppl 2):1999;31-38.
13. Farde L., Halldin C., Stone-Elander S., Sedvall S.G. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390, and 11C-raclopride. Psychopharmacol. 1987:1987;278-284.
14. Feldman J.M. Monoamine and diaminie oxidase activity in the diagnosis of carcinoid tumors. Cancer. 1985:1985;2855-2860.
15. Feldman J., Moore J. Biogenic amines in carcinoid tumors. Biogenic Amines. 1989:1989;247-252.
16. Goller L., Bergstrom M., Nilsson S., Westerberg G., Langstrom B. MAO-A enzyme binding in bladder cancer characterized with (11C)harmine in frozen section autoradiography. Oncol. Rep. 1995:1995;717-721.
17. Halldin C., Farde L., Lundkvist C., Ginovart N., Nakashima Y., Karlsson P., Swahn C.G. [11C] beta-CIT-FE; a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse. 1996:1996;386-390.
18. Huttner W.B., Gerdes H.H., Rosa P. The granin (chromogranin/ secretogranin) family. Trends Biochem. Sci. 1991:1991;27-30.
19. Kweckeboom D.J., Krenning E.P., Bakker W.H., Oey H.Y., Krooij P.P., Lamberts S.W. Somatostatin analogue scintigraphy in carcinoid tumors. Eur. J. Nucl. Med. 1993:1993;283-292.
20. Langley K. The neuroendocrine concept today. Ann. NY Acad. Sci. 1994:1994;1-17.
21. Lebtahi R., Cadiot G., Sarda L., Daou D., Faraggi M., Petegnief Y., Mignon M., Le Guludec D. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J. Nucl. Med. 1997:1997;853-858.
22. May T., Pawlik M., Rommelsbacher H. 3-H-harman binding experiments II Regional and subcellular distribution of specific 3-H-harman binding, and monoamineoxidase subtypes A, and B activity in marmoset, and rat . J. Neurochem. 1991:1991;500-508.
23. Nishiyama S., Sato K., Harada N., Kakiushi T., Tsukada H. Development and evaluation of muscarinic cholinergic receptor ligands N-[11C]ethyl-4- piperidyl benzilate, and N- [11C]propyl-4-piperidyl benzilate a PET study in comparison with N-[11C]methyl-4- piperidylbenzilate in the conscious monkey brain . Nucl. Med. Biol. 2000:2000;733-740.
24. Norheim I., Öberg K., Theodorsson-Norheim E., Lindgren P.G., Lungqvist G., Magnusson A., Wide L., Wilander E. Malignant carcinoid tumors; an analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann. Surg. 1987:1987;115-125.
25. Nyberg S., Farde L., Eriksson L., Halldin C., Eriksson B. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacol. 1993:1993;265-272.
26. Panagiotidis G., Stenström A., Lundquist I. Influence of beta 2-adrenoceptor stimulation, and glucose on islet monoamine oxidase activity, and insulin secretory response in the mouse. Pancreas. 1993:1993;368-374.
27. Pearse A.G.E. The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series, and the embryologic, physiologic, and pathologic implications of the concept. J. Histochem. Cytochem. 1969:1969;303-313.
28. Pearse A.G.E. The APUD concept and hormone production. Clin. Endocrinol. Metab. 1980:1980;211-222.
29. Rota Kops E., Herzog H., Schmid A., Holte S., Feinendegen L.E. Performance characteristics of an eight ring whole body PET-scanner. J. Comput. Assist. Tomogr. 1990:1990;437-445.
30. Saura J., Kettler R., DaPrada M., Richards J.G. Quantitative enzyme radioautography with 3-H-RO 41-1049, and 3-H-RO 19-6327 in vitro Localization, and abundance of MAO-A, and MAO-B in rat CNS, peripherial organs, and human brain . J. Neurosci. 1992:1992;1977-1999.
31. Sundler F., Håkansson R., Loren I., Lundqvist I. Amine storage and function in peptide hormone producing cells. Invest. Cell. Pathol. 1980:1980;87-103.
32. Westberg G., Ahlman H., Nilsson O., Illerskog A., Wangberg B. Secretory patterns of tryptophan metabolites in midgut carcinoid tumor cells. Neurochem. Res. 1997:1997;977-983.
33. Wiedenmann B., Ahnert-Higler G., Kvols L.K., Riecken E.O. New molecular aspects for the diagnosis, and treatment of neuroendocrine gastroenteropancreatic tumors. Ann. N Y Acad. Sci. 1994:1994;515-525.
34. Zeiger M.A., Shawker T.H., Norton J.A. Use of intraoperative ultrasonography to localize islet cell tumors. World J. Surg. 1993:1993;448-454.
35. Zimmer T., Stolzel U., Bader M., Koppenhagen K., Hamm B., Buhr H., Riecken E.O., Wiedenmann B. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut. 1996:1996;562-568.
36. Yanai K., Ryu J.H., Watanabe T., Iwata R., Ido T. Receptor autoradiography with 11-C and 3-H-labelled ligands visualized by imaging plates. Neurorep. 1992:1992;961-964.
37. Oberg K. Interferon in the management of neuroendocirne GEP-tumors. Digestion. 62:(suppl 1):2000;92-97.
38. Orlefors H., Sundin A., Ahlstrom H., Bjurling P., Bergstrom M., Lilja A., Langstrom B., Oberg K., Eriksson B. Postitron emission tomography with 5-hydroxytryptophan in neuroendocrine tumors. J. Clin. Oncol. 1998:1998;2534-2541.